Status:
RECRUITING
Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal Surgery
Lead Sponsor:
Rhendra Hardy Mohamad Zaini
Conditions:
Atelectasis, Postoperative
Pulmonary Function; Newborn, Abnormal
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The goal of this clincal trial is to determine the differences in few parameter of lung function (ie Forced Vital Capacity (FCV)) between Sugammadex and conventional reversal in laparoscopic abdominal...
Detailed Description
Postoperative Pulmonary Complications (PPCs) are not uncommon. They increase healthcare resource usage as well as increase mortality of the patients. There are many definitions published in literature...
Eligibility Criteria
Inclusion
- Diagnosed / suspected: appendicitis or cholelithiasis
- Planned for laparoscopic operation under general anaesthesia
- ASA I-III
Exclusion
- Unstable haemodynamic status
- Patient refusal to participate
- Altered mental status, cognitive function or mental disorder
- Admission to postoperative care unit (PACU) under mechanical ventilation
- Hypersensitivity to any of the drugs
- Acute or chronic lung diseases
- Neuromuscular disorders
- Myocardial infarction or coronary occlusion three months prior surgery
- Obesity BMI more or equal 30
- Intubation prior operating room arrival
- Pregnancy
- Converted to open surgery
Key Trial Info
Start Date :
December 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06210165
Start Date
December 7 2022
End Date
June 1 2024
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Science Malaysia Hospital
Kubang Kerian, Kelantan, Malaysia, 16150